Testosterone Replacement Therapy May Slow COPD Progression

by Adeline Dorcas on  September 14, 2018 at 4:56 PM Research News
RSS Email Print This Page Comment bookmark
Font : A-A+

Testosterone replacement therapy may help slow the progression of chronic obstructive pulmonary disease (COPD), according to a new study led by a team of researchers from The University of Texas Medical Branch at Galveston. The findings of the study are published in the journal Chronic Respiratory Disease.
Testosterone Replacement Therapy May Slow COPD Progression
Testosterone Replacement Therapy May Slow COPD Progression

Chronic obstructive pulmonary disease, or COPD, is predicted by the World Health Organization to be the third-leading cause of illness and death internationally by 2030. Low testosterone is common in men with COPD and may worsen their condition.

Men with COPD have shortness of breath and often take steroid-based medications for an extended time, both of which increase their risk of low testosterone.

"Previous studies have suggested that testosterone replacement therapy may have a positive effect on lung function in men with COPD," said Jacques Baillargeon, UTMB professor in preventive medicine and community health. "However, we are the first to conduct a large-scale nationally representative study on this association."

The goal of the study was to find out whether testosterone replacement therapy reduced the risk of respiratory hospitalizations in middle-aged and older men with COPD.

Using the Clinformatics Data Mart, a database of one of the largest commercially insured populations in the U.S., Baillargeon, and colleagues examined data of 450 men aged 40 to 63 with COPD who began testosterone replacement therapy between 2005 and 2014.

They also used the national Medicare database to study data from 253 men with COPD aged 66 and older who initiated testosterone replacement therapy between 2008 and 2013.

"We found that testosterone users had a greater decrease in respiratory hospitalizations compared with non-users. Specifically, middle-aged testosterone replacement therapy users had a 4.2 percent greater decrease in respiratory hospitalizations compared with non-users, and older testosterone replacement therapy users had a 9.1 percent greater decrease in respiratory hospitalizations compared with non-users," said Baillargeon.

"The findings suggest that testosterone replacement therapy may slow the progression of disease in men with COPD."

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

Recommended Reading

More News on:

Reiki and Pranic Healing Andropause / Male Menopause Adreno Cortical Carcinoma Pneumoconiosis Pulmonary Arterial Hypertension Is Your Man Moody? Chronic Obstructive Pulmonary Disease Emphysema Pneumonectomy Chronic Bronchitis 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive